Abstract
Background
A two-stage revision total knee arthroplasty is recognized as the gold standard in the treatment of infection. However, traditional spacers limit function in the interval between the two stages and may cause instability, scarring, and bone erosion. The PROSTALAC knee spacer is an antibiotic-loaded cement articulating spacer that allows some movement of the knee between stages. Whether motion enhances long-term function is unknown.
Questions/purposes
We therefore identify the rate of control of infection using the PROSTALAC exchange spacer and to assess the clinical outcome after implantation with a definitive implant.
Methods
We retrospectively reviewed 115 knees that underwent two-stage exchange with the PROSTALAC spacer. Forty-eight of these had a minimum followup of 5 years (mean, 9 years; range, 5–12 years).
Results
At last review, 101 of the 115 knees (88%) had no evidence of infection. Of the 14 knees that became reinfected, four were from the same organism and 10 were with a different organism. After further intervention, using the two-stage approach again, the infection was controlled in 12 of the 14 initially reinfected cases, resulting in a failure to cure in only two cases. We observed improvements in mean WOMAC, Oxford, UCLA, and Patient Satisfaction scores at last review.
Conclusions
The PROSTALAC functional spacer was associated with a 98% rate of control of infection and improvements in the quality-of-life outcomes in the treatment of chronically infected total knee arthroplasties.
Level of Evidence
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Bengtson S, Knutson K. The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand. 1991;62:301–311.
Bengtson S, Knutson K, Lidgren L. Revision of infected knee arthroplasty. Acta Orthop Scand. 1986;57:489–494.
Booth RE, Lotke PA. The results of spacer block technique in revision of infected total knee arthroplasty. Clin Orthop Relat Res. 1989;248:57–60.
Borden LS, Gearen PF. Infected total knee arthroplasty. A protocol for management. J Arthroplasty. 1987;2:27–36.
Brause BD. Infected total knee replacement: diagnostic, therapeutic, and prophylactic considerations. Orthop Clin North Am. 1982;13:245–249.
Calton TF, Fehring TK, Griffin WL. Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res. 1997;345:148–154.
Charnley J. The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg Br. 1972;54:61–76.
Deburge A, Guepar. Guepar hinge prosthesis: complications and results with two years’ follow-up. Clin Orthop Relat Res. 1976;120:47–53.
Duncan CP, Beauchamp CP, Masri BA, McGraw RW, Paris NJ, Breault MJ. The antibiotic loaded joint replacement system. A novel approach to the management of the infected knee replacement. J Bone Joint Surg Am. 1992;74:296.
Emerson RH, Muncie M, Tarbox TR, Higgins LL. Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res. 2002;404:132–138.
Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis. The Ranawat Award. Clin Orthop Relat Res. 2000;380:9–16.
Gill GS, Joshi AB. Long-term results of cemented, posterior cruciate ligament-retaining total knee arthroplasty in osteoarthritis. Am J Knee Surg. 2001;14:209–214.
Goldman RT, Scuderi GR, Insall JN. 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res. 1996;331:118–124.
Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, Duncan CP. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg Am. 2007;89:1409–1416.
Haddad FS, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP. The PROSTALAC functional spacer in two-stage revision for infected knee replacements. Prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br. 2000;82:807–812.
Insall JN. Infection of total knee arthroplasty. Instr Course Lect. 1986;35:319–324.
Insall JN. Surgical technique and instrumentation in total knee arthroplasty. In: Insall JN, Windsor RE, Scott WN, Kelly MA, Aglietti P, eds. Surgery of the Knee. New York, NY: Churchill Livingstone; 1993:739–804.
Insall JN, Thompson FM, Brause BD. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J Bone Joint Surg Am. 1983;65:1087–1098.
Insall JN, Thompson FM, Brause BD. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J Bone Joint Surg Am. 2002;84:490.
Jacobs MA, Hungerford DS, Krackow KA, Lennox DW. Revision of septic total knee arthroplasty. Clin Orthop Relat Res. 1989;238:159–166.
Kelly MA, Clarke HD. Long-term results of posterior cruciate-substituting total knee arthroplasty. Clin Orthop Relat Res. 2002;404:51–57.
Konig A, Kirschner S. Long-term results in total knee arthroplasty [in German]. Orthopade. 2003;32:516–526.
Meek RM, Dunlop D, Garbuz DS, McGraw RW, Greidanus NV, Masri BA. Patient satisfaction and functional status after aseptic versus septic revision total knee arthroplasty using the PROSTALAC articulating spacer. J Arthroplasty. 2004;19:874–879.
Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus NV, McGraw R, Duncan CP. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85:1888–1892.
Ranawat CS, Flynn WF, Saddler S, Hansraj KK, Maynard MJ. Long-term results of the total condylar knee arthroplasty. A 15-year survivorship study. Clin Orthop Relat Res. 1993;286:94–102.
Rand JA, Chao EY, Stauffer RN. Kinematic rotating-hinge total knee arthroplasty. J Bone Joint Surg Am. 1987;69:489–497.
Rand JA, Fitzgerald RH. Diagnosis and management of the infected total knee arthroplasty. Orthop Clin North Am. 1989;20:201–210.
Rorabeck CH. Session IV: salvage of the infected total knee replacement. Infection: the problem. Clin Orthop Relat Res. 2002;404:113–115.
Rosenberg AG, Haas B, Barden R, Marquez D, Landon GC, Galante JO. Salvage of infected total knee arthroplasty. Clin Orthop Relat Res. 1988;226:29–33.
Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–284.
Spangehl MJ, Hanssen AD. Management of the infected total knee replacement. Curr Opin Orthop. 2002;13:23–29.
Teeny SM, Dorr L, Murata G, Conaty P. Treatment of infected total knee arthroplasty. Irrigation and débridement versus two-stage reimplantation. J Arthroplasty. 1990;5:35–39.
Walker RH, Schurman DJ. Management of infected total knee arthroplasties. Clin Orthop Relat Res. 1984;186:81–89.
Whiteside LA. Treatment of infected total knee arthroplasty. Clin Orthop Relat Res. 1994;299:169–172.
Wilde AH. Management of infected knee and hip prostheses. Curr Opin Rheumatol. 1994;6:172–176.
Wilde AH, Ruth JT. Two-stage reimplantation in infected total knee arthroplasty. Clin Orthop Relat Res. 1988;236:23–35.
Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72:878–883.
Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD. Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J Bone Joint Surg Am. 1990;72:272–278.
Woods GW, Lionberger DR, Tullos HS. Failed total knee arthroplasty. Revision and arthrodesis for infection and noninfectious complications. Clin Orthop Relat Res. 1983;173:184–190.
Acknowledgments
We thank Daphne Savoy, research coordinator, without whose valuable help this article would not have been possible, and Eric Sayre for performing the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
About this article
Cite this article
Gooding, C.R., Masri, B.A., Duncan, C.P. et al. Durable Infection Control and Function With the PROSTALAC Spacer in Two-stage Revision for Infected Knee Arthroplasty. Clin Orthop Relat Res 469, 985–993 (2011). https://doi.org/10.1007/s11999-010-1579-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-010-1579-y